TY - JOUR
AU - Lima Silveira E
AU - Sousa JR
AU - Aarão TLS
AU - Fuzii HT
AU - Dias Junior LB
AU - Oliveira Carneiro FR
AU - Quaresma JAS
AB - <p><em>To the Editor:</em> Leprosy is an infectious disease caused by <em>Mycobacterium leprae</em> with clinical manifestations that are vastly dependent on the host's immune response. The role of Th22 cells in the immunopathogenicity of leprosy has yet to be characterized.</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

BT - Journal of the American Academy of Dermatology
C1 - <p>http://www.ncbi.nlm.nih.gov/pubmed/25773413?dopt=Abstract</p>

CN - DELIMASILVEIRA2015
DO - 10.1016/j.jaad.2014.11.023
IS - 4
J2 - J. Am. Acad. Dermatol.
LA - eng
N2 - <p><em>To the Editor:</em> Leprosy is an infectious disease caused by <em>Mycobacterium leprae</em> with clinical manifestations that are vastly dependent on the host's immune response. The role of Th22 cells in the immunopathogenicity of leprosy has yet to be characterized.</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

<p>&nbsp;</p>

PY - 2015
SP - 729
EP - 30
T2 - Journal of the American Academy of Dermatology
TI - New immunologic pathways in the pathogenesis of leprosy: Role for Th22 cytokines in the polar forms of the disease.
UR - http://www.jaad.org/article/S0190-9622(14)02208-7/pdf
VL - 72
SN - 1097-6787
ER -